21 related articles for article (PubMed ID: 38548114)
1. Stereotactic Body Radiation Therapy for Sacral Metastases: Deviation From Recommended Target Volume Delineation Increases the Risk of Local Failure.
Moore-Palhares D; Zeng KL; Tseng CL; Chen H; Myrehaug S; Soliman H; Maralani P; Larouche J; Shakil H; Jerzak K; Ruschin M; Zhang B; Atenafu EG; Sahgal A; Detsky J
Int J Radiat Oncol Biol Phys; 2024 Jul; 119(4):1110-1121. PubMed ID: 38395085
[TBL] [Abstract][Full Text] [Related]
2. Early Experience With Two-Fraction Spine Stereotactic Body Radiation Therapy in Treating Spinal Metastases.
Ekpunobi IO; McClelland S
Am J Clin Oncol; 2024 Jun; 47(6):289-290. PubMed ID: 38372269
[TBL] [Abstract][Full Text] [Related]
3. Stereotactic radiosurgery for prostate cancer spine metastases: local control and fracture risk using a simultaneous integrated boost approach.
Beckham TH; Rooney MK; Cifter G; Bernard V; McAleer MF; De BS; Tom MC; Perni S; Wang C; Swanson T; Tatsui CE; Alvarez-Breckenridge C; North R; Rhines LD; Tang C; Logothetis C; Amini B; Li J; Yeboa DN; Ghia AJ
J Neurosurg Spine; 2024 Jun; ():1-9. PubMed ID: 38875722
[TBL] [Abstract][Full Text] [Related]
4. Stereotactic body radiation therapy for benign spine tumors: is dose de-escalation appropriate?
Kalash R; Glaser SM; Flickinger JC; Burton S; Heron DE; Gerszten PC; Engh JA; Amankulor NM; Vargo JA
J Neurosurg Spine; 2018 Aug; 29(2):220-225. PubMed ID: 29799334
[TBL] [Abstract][Full Text] [Related]
5. Re-irradiation stereotactic body radiotherapy for spinal metastases: a multi-institutional outcome analysis.
Hashmi A; Guckenberger M; Kersh R; Gerszten PC; Mantel F; Grills IS; Flickinger JC; Shin JH; Fahim DK; Winey B; Oh K; John Cho BC; Létourneau D; Sheehan J; Sahgal A
J Neurosurg Spine; 2016 Nov; 25(5):646-653. PubMed ID: 27341054
[TBL] [Abstract][Full Text] [Related]
6. Vertebral compression fractures after stereotactic body radiation therapy: a large, multi-institutional, multinational evaluation.
Jawad MS; Fahim DK; Gerszten PC; Flickinger JC; Sahgal A; Grills IS; Sheehan J; Kersh R; Shin J; Oh K; Mantel F; Guckenberger M;
J Neurosurg Spine; 2016 Jun; 24(6):928-36. PubMed ID: 26895526
[TBL] [Abstract][Full Text] [Related]
7. Myositis following spine radiosurgery for metastatic disease: a case series.
Lockney DT; Jia AY; Lis E; Lockney NA; Liu C; Hopkins B; Higginson DS; Yamada Y; Laufer I; Bilsky M; Schmitt AM
J Neurosurg Spine; 2018 Apr; 28(4):416-421. PubMed ID: 29372858
[TBL] [Abstract][Full Text] [Related]
8. Imaging-Based Outcomes for 24 Gy in 2 Daily Fractions for Patients with de Novo Spinal Metastases Treated With Spine Stereotactic Body Radiation Therapy (SBRT).
Tseng CL; Soliman H; Myrehaug S; Lee YK; Ruschin M; Atenafu EG; Campbell M; Maralani P; Yang V; Yee A; Sahgal A
Int J Radiat Oncol Biol Phys; 2018 Nov; 102(3):499-507. PubMed ID: 30003994
[TBL] [Abstract][Full Text] [Related]
9. Stereotactic body radiotherapy for spine metastases: a review of 24 Gy in 2 daily fractions.
Nguyen EK; Ruschin M; Zhang B; Soliman H; Myrehaug S; Detsky J; Chen H; Sahgal A; Tseng CL
J Neurooncol; 2023 May; 163(1):15-27. PubMed ID: 37155133
[TBL] [Abstract][Full Text] [Related]
10. Stereotactic Body Radiation Therapy for Spinal Metastases: Tumor Control Probability Analyses and Recommended Reporting Standards.
Soltys SG; Grimm J; Milano MT; Xue J; Sahgal A; Yorke E; Yamada Y; Ding GX; Li XA; Lovelock DM; Jackson A; Ma L; El Naqa I; Gibbs IC; Marks LB; Benedict S
Int J Radiat Oncol Biol Phys; 2021 May; 110(1):112-123. PubMed ID: 33516580
[TBL] [Abstract][Full Text] [Related]
11. Assessment of minimum target dose as a predictor of local failure after spine SBRT.
Kowalchuk RO; Mullikin TC; Spears GM; Johnson-Tesch BA; Rose PS; Siontis BL; Kun Kim D; Costello BA; Morris JM; Gao RW; Shiraishi S; Lucido JJ; Olivier KR; Owen D; Stish BJ; Waddle MR; Laack NN; Park SS; Brown PD; Merrell KW
Radiother Oncol; 2024 Jun; 195():110260. PubMed ID: 38548114
[TBL] [Abstract][Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]